Scilex Holding Co. (SCLX)
5.04
-0.33
(-6.15%)
USD |
NASDAQ |
Sep 18, 16:00
5.09
+0.05
(+0.99%)
After-Hours: 20:00
Scilex Cash from Investing (Quarterly) : 8.452M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.452M |
| March 31, 2026 | -9.16M |
| December 31, 2025 | 4.831M |
| September 30, 2025 | -0.1567M |
| June 30, 2025 | -0.1627M |
| March 31, 2025 | -0.395M |
| December 31, 2024 | -0.1697M |
| September 30, 2024 | -2.215M |
| June 30, 2024 | -0.1486M |
| March 31, 2024 | -0.15M |
| December 31, 2023 | -0.1663M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.1539M |
| June 30, 2023 | -0.008M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -40.20M |
| September 30, 2022 | 0.0065M |
| June 30, 2022 | -2.042M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 137.95M |
| September 30, 2021 | 1.449M |
| June 30, 2021 | -0.0155M |
| March 31, 2021 | -139.38M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 3.920M |
| Semnur Pharmaceuticals, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.723M |
| Cash from Financing (Quarterly) | -4.491M |
| Free Cash Flow | -61.82M |
| Free Cash Flow Per Share (Quarterly) | -1.832 |
| Free Cash Flow to Equity (Quarterly) | -12.25M |
| Free Cash Flow to Firm (Quarterly) | -6.521M |
| Free Cash Flow Yield | -151.3% |